Cargando…

Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilization

BACKGROUND: Muscle wasting is a hallmark of many chronic conditions but also of aging and results in a progressive functional decline leading ultimately to disability. Androgens, such as testosterone were proposed as therapy to counteract muscle atrophy. However, this treatment is associated with po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanqué, Roland, Lepescheux, Liên, Auberval, Marielle, Minet, Dominique, Merciris, Didier, Cottereaux, Céline, Clément-Lacroix, Philippe, Delerive, Philippe, Namour, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167280/ https://www.ncbi.nlm.nih.gov/pubmed/25185887 http://dx.doi.org/10.1186/1471-2474-15-291

Ejemplares similares

Population Pharmacokinetic and Pharmacodynamic Analysis of GLPG1690, an Autotaxin Inhibitor, in Healthy Volunteers and Patients with Idiopathic Pulmonary Fibrosis
por: Taneja, Amit, et al.
Publicado: (2019)

Author’s Reply to Srinivas: “Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection”
por: Namour, Florence
Publicado: (2015)

CFTR Rescue in Intestinal Organoids with GLPG/ABBV-2737, ABBV/GLPG-2222 and ABBV/GLPG-2451 Triple Therapy
por: de Poel, Eyleen, et al.
Publicado: (2021)

Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects
por: Namour, Florence, et al.
Publicado: (2016)

Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection
por: Namour, Florence, et al.
Publicado: (2015)

Pharmacokinetics, Safety, and Tolerability of GLPG0259, a Mitogen-Activated Protein Kinase-Activated Protein Kinase 5 (MAPKAPK5) Inhibitor, Given as Single and Multiple Doses to Healthy Male Subjects
por: Namour, Florence, et al.
Publicado: (2012)

A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies
por: Cirkel, Geert A., et al.
Publicado: (2016)

Mutation of TonB-Dependent Receptor Encoding Gene MCR_0492 Potentially Associates with Macrolides Resistance in Moraxella catarrhalis Isolates
por: Zhang, Zhen, et al.
Publicado: (2022)

How to Successfully Generate an Alternative Approach to a Thorough QT Study: GLPG1972 as an Example
por: Meyer, Claudia, et al.
Publicado: (2022)

P.0492 Impact of mood and stress during COVID-19 lockdown on perceived immune fitness and the presence and severity of COVID-19 symptoms
por: Kiani, P., et al.
Publicado: (2021)

Influence of Androgen Receptor in Vascular Cells on Reperfusion following Hindlimb Ischaemia
por: Wu, Junxi, et al.
Publicado: (2016)

Effects of joint immobilization and hindlimb unloading on collagen fibers of soleus muscles in rats
por: Matsumoto, Tomohiro, et al.
Publicado: (2017)

Steric trapping reveals a cooperativity network in the intramembrane protease GlpG
por: Guo, Ruiqiong, et al.
Publicado: (2016)

Identifying the molecular target sites for CFTR potentiators GLPG1837 and VX-770
por: Yeh, Han-I, et al.
Publicado: (2019)

The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis
por: Puengel, Tobias, et al.
Publicado: (2020)

GLPG1205, a GPR84 Modulator: Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Subjects
por: Timmis, Helen, et al.
Publicado: (2021)

Delayed Recovery of Skeletal Muscle Mass following Hindlimb Immobilization in mTOR Heterozygous Mice
por: Lang, Susan M., et al.
Publicado: (2012)

The Rhomboid Protease GlpG Promotes the Persistence of Extraintestinal Pathogenic Escherichia coli within the Gut
por: Russell, Colin W., et al.
Publicado: (2017)

Pharmacokinetics and Metabolism of Ziritaxestat (GLPG1690) in Healthy Male Volunteers Following Intravenous and Oral Administration
por: Helmer, Eric, et al.
Publicado: (2021)

GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trial
por: Strambu, Irina R., et al.
Publicado: (2023)

Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines In Vitro and In Vivo
por: Colapietro, Alessandro, et al.
Publicado: (2020)

Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials
por: van der Aar, Ellen, et al.
Publicado: (2019)

The rhomboid protease GlpG has weak interaction energies in its active site hydrogen bond network
por: Gaffney, Kristen A., et al.
Publicado: (2019)

Leucine Supplementation Decreases HDAC4 Expression and Nuclear Localization in Skeletal Muscle Fiber of Rats Submitted to Hindlimb Immobilization
por: Alves, Paula K. N., et al.
Publicado: (2020)

Poster 120: Understanding the Biological Basis of Contracture Using a Mouse Model of Single Hindlimb Immobilization-Induced Fibrosis
por: Lessard, Samantha, et al.
Publicado: (2023)

Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
por: Megiorni, Francesca, et al.
Publicado: (2017)

The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models
por: Gravina, Giovanni Luca, et al.
Publicado: (2019)

Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR Modulators
por: de Wilde, Gert, et al.
Publicado: (2019)

Safety, Pharmacokinetics, and Pharmacodynamics of the ADAMTS‐5 Inhibitor GLPG1972/S201086 in Healthy Volunteers and Participants With Osteoarthritis of the Knee or Hip
por: van der Aar, Ellen, et al.
Publicado: (2021)

Repressors of mTORC1 act to blunt the anabolic response to feeding in the soleus muscle of a cast‐immobilized mouse hindlimb
por: Shimkus, Kevin L., et al.
Publicado: (2018)

Effect of short-term hindlimb immobilization on skeletal muscle atrophy and the transcriptome in a low compared with high responder to endurance training model
por: Thompson, Jamie-Lee M., et al.
Publicado: (2022)

Murine Model of Hindlimb Ischemia
por: Niiyama, Hiroshi, et al.
Publicado: (2009)

SAGE profiling of the forelimb and hindlimb
por: Logan, Malcolm
Publicado: (2002)

Cistanche tubulosa (Schenk) Wight Extract Enhances Hindlimb Performance and Attenuates Myosin Heavy Chain IId/IIx Expression in Cast-Immobilized Mice
por: Kimbara, Yoshiyuki, et al.
Publicado: (2019)

An experimental model of ischemia in rabbit hindlimb.
por: Hong, J. H., et al.
Publicado: (2001)

Region-Dependent Increase of Cerebral Blood Flow During Electrically Induced Contraction of the Hindlimbs in Rats
por: Chaney, Remi, et al.
Publicado: (2022)

Changes in REDD1, REDD2, and atrogene mRNA expression are prevented in skeletal muscle fixed in a stretched position during hindlimb immobilization
por: Kelleher, Andrew R., et al.
Publicado: (2014)

Synergetic effect of soluble whey protein hydrolysate and Panax ginseng berry extract on muscle atrophy in hindlimb-immobilized C57BL/6 mice
por: Han, Min Ji, et al.
Publicado: (2022)

Influence of Brain Stem on Axial and Hindlimb Spinal Locomotor Rhythm Generating Circuits of the Neonatal Mouse
por: Jean-Xavier, Céline, et al.
Publicado: (2018)

The design of a randomized, placebo-controlled, dose-ranging trial to investigate the efficacy and safety of the ADAMTS-5 inhibitor S201086/GLPG1972 in knee osteoarthritis
por: Imbert, Olivier, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_av24404kp20rq5hdecjclq1pjb